The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Tranylcypromine: Effects on Norepinephrine Metabolism in Rat Brain

Published Online:https://doi.org/10.1176/ajp.126.7.925

This investigation examines the effects of tranylcypromine on the uptake, release, and metabolism of intracisternally administered tritiated norepinephrine (norepinephrine-H3) in rat brain. The findings suggest that, in addition to being a potent inhibitor of the enzyme monoamine oxidase, tranylcypromine discharges norepinephrine extraneuronally onto receptors and possibly also inhibits the neuronal reuptake of this amine. These neuropharmacological effects of tranylcypromine may possibly account for the greater clinical efficacy of tranylcypromine in the treatment of some depressed patients and the higher incidence of hypertensive cerebrovascular reactions when this drug is compared with other monoamine oxidase inhibitors.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.